FIBROLAMELLAR CARCINOMA
Clinical trials for FIBROLAMELLAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new FIBROLAMELLAR CARCINOMA trials appear
Sign up with your email to follow new studies for FIBROLAMELLAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with liver cancer: international trial tests smarter chemo cocktails
Disease control OngoingThis study tests different combinations of chemotherapy drugs in children and young adults with liver cancer (hepatoblastoma or hepatocellular carcinoma). The goal is to see which combinations work best alongside surgery to stop tumors from growing or spreading. About 537 partici…
Matched conditions: FIBROLAMELLAR CARCINOMA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 26, 2026 08:55 UTC
-
New drug duo aims to boost immune system against tough cancers
Disease control OngoingThis early-stage study tests two experimental drugs (botensilimab and balstilimab) that help the immune system fight cancer. It includes about 500 adults with advanced solid tumors like lung, ovarian, or colorectal cancer that haven't responded to standard treatments. The main go…
Matched conditions: FIBROLAMELLAR CARCINOMA
Phase: PHASE1 • Sponsor: Agenus Inc. • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New immunotherapy combo shows promise for young cancer patients
Disease control OngoingThis study tests two immunotherapy drugs, cobolimab and dostarlimab, together in children and young adults (up to age 21) with advanced solid tumors that have not responded to other treatments. The goal is to find the safest dose and see if the combination can shrink tumors. The …
Matched conditions: FIBROLAMELLAR CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 22, 2026 13:50 UTC